Boxer Capital’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,727,388
| Closed | -$79.3M | – | 46 |
|
|
2024
Q3 | $79.3M | Hold |
1,727,388
| – | – | 3.89% | 9 |
|
|
2024
Q2 | $70.6M | Hold |
1,727,388
| – | – | 3.72% | 10 |
|
|
2024
Q1 | $44.1M | Buy |
1,727,388
+606,061
| +54% | +$15.5M | 2.18% | 14 |
|
|
2023
Q4 | $10.1M | Hold |
1,121,327
| – | – | 0.51% | 34 |
|
|
2023
Q3 | $7.15M | Hold |
1,121,327
| – | – | 0.38% | 48 |
|
|
2023
Q2 | $12.4M | Hold |
1,121,327
| – | – | 0.58% | 44 |
|
|
2023
Q1 | $17.2M | Hold |
1,121,327
| – | – | 0.85% | 36 |
|
|
2022
Q4 | $24.9M | Hold |
1,121,327
| – | – | 1.31% | 29 |
|
|
2022
Q3 | $18.3M | Hold |
1,121,327
| – | – | 1.03% | 35 |
|
|
2022
Q2 | $16.3M | Hold |
1,121,327
| – | – | 1.03% | 34 |
|
|
2022
Q1 | $20.7M | Hold |
1,121,327
| – | – | 1.06% | 30 |
|
|
2021
Q4 | $26.7M | Hold |
1,121,327
| – | – | 1.04% | 25 |
|
|
2021
Q3 | $27.6M | Hold |
1,121,327
| – | – | 0.96% | 29 |
|
|
2021
Q2 | $27.7M | Hold |
1,121,327
| – | – | 0.98% | 27 |
|
|
2021
Q1 | $24.5M | Hold |
1,121,327
| – | – | 0.83% | 35 |
|
|
2020
Q4 | $28.6M | Hold |
1,121,327
| – | – | 0.92% | 31 |
|
|
2020
Q3 | $31.6M | Hold |
1,121,327
| – | – | 1.09% | 25 |
|
|
2020
Q2 | $31.7M | Buy |
+1,121,327
| New | +$31.7M | 1.39% | 25 |
|